Annual Working Capital
-$243.00 K
-$2.02 M-113.70%
31 December 2023
Summary:
Akari Therapeutics annual working capital is currently -$243.00 thousand, with the most recent change of -$2.02 million (-113.70%) on 31 December 2023. During the last 3 years, it has fallen by -$9.60 million (-102.60%). AKTX annual working capital is now -100.50% below its all-time high of $48.53 million, reached on 31 December 2015.AKTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
-$6.69 M
-$2.99 M-80.77%
01 September 2024
Summary:
Akari Therapeutics quarterly working capital is currently -$6.69 million, with the most recent change of -$2.99 million (-80.77%) on 01 September 2024. AKTX quarterly working capital is now -113.79% below its all-time high of $48.53 million, reached on 31 December 2015.AKTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKTX Working Capital Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -113.7% | - |
3 y3 years | -102.6% | -159.0% |
5 y5 years | -109.6% | -308.4% |
AKTX Working Capital High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -102.6% | at low | -148.1% | at low |
5 y | 5 years | -102.6% | at low | -148.1% | at low |
alltime | all time | -100.5% | +91.1% | -113.8% | at low |
Akari Therapeutics Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -$6.69 M(+80.8%) |
June 2024 | - | -$3.70 M(+4.2%) |
Mar 2024 | - | -$3.55 M(+1362.1%) |
Dec 2023 | -$243.00 K(-113.7%) | -$243.00 K(-108.8%) |
June 2023 | - | $2.77 M(-66.7%) |
Dec 2022 | $1.77 M(-67.9%) | - |
June 2022 | - | $8.31 M(-40.3%) |
Mar 2022 | - | $13.91 M(+151.5%) |
Dec 2021 | $5.53 M(-40.9%) | $5.53 M(-51.2%) |
Sept 2021 | - | $11.34 M(+625.7%) |
June 2021 | - | $1.56 M(-60.0%) |
Mar 2021 | - | $3.91 M(-58.2%) |
Dec 2020 | $9.36 M(<-9900.0%) | $9.36 M(+93.7%) |
Sept 2020 | - | $4.83 M(+45.9%) |
June 2020 | - | $3.31 M(+85.5%) |
Mar 2020 | - | $1.79 M(-6594.2%) |
Dec 2019 | -$27.50 K(-101.1%) | -$27.50 K(-100.9%) |
Sept 2019 | - | $3.21 M(-324.2%) |
June 2019 | - | -$1.43 M(-240.0%) |
Mar 2019 | - | $1.02 M(-59.6%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2018 | $2.54 M(-85.1%) | $2.54 M(-57.0%) |
Sept 2018 | - | $5.89 M(-28.5%) |
June 2018 | - | $8.24 M(-49.1%) |
Mar 2018 | - | $16.19 M(-4.6%) |
Dec 2017 | $16.96 M(-50.0%) | $16.96 M(+31.9%) |
Sept 2017 | - | $12.86 M(-43.2%) |
June 2017 | - | $22.66 M(+2.0%) |
Mar 2017 | - | $22.22 M(-34.5%) |
Dec 2016 | $33.92 M(-30.1%) | $33.92 M(-17.0%) |
Sept 2016 | - | $40.85 M(+1.2%) |
June 2016 | - | $40.38 M(-12.5%) |
Mar 2016 | - | $46.14 M(-4.9%) |
Dec 2015 | $48.53 M(+2143.0%) | $48.53 M(+18.0%) |
Sept 2015 | - | $41.14 M(+1999.1%) |
June 2015 | - | $1.96 M(-41.7%) |
Mar 2015 | - | $3.36 M(+55.4%) |
Dec 2014 | $2.16 M(-67.2%) | $2.16 M |
Dec 2013 | $6.60 M(-341.6%) | - |
Dec 2012 | -$2.73 M(+23.7%) | - |
Dec 2011 | -$2.21 M | - |
FAQ
- What is Akari Therapeutics annual working capital?
- What is the all time high annual working capital for Akari Therapeutics?
- What is Akari Therapeutics annual working capital year-on-year change?
- What is Akari Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Akari Therapeutics?
What is Akari Therapeutics annual working capital?
The current annual working capital of AKTX is -$243.00 K
What is the all time high annual working capital for Akari Therapeutics?
Akari Therapeutics all-time high annual working capital is $48.53 M
What is Akari Therapeutics annual working capital year-on-year change?
Over the past year, AKTX annual working capital has changed by -$2.02 M (-113.70%)
What is Akari Therapeutics quarterly working capital?
The current quarterly working capital of AKTX is -$6.69 M
What is the all time high quarterly working capital for Akari Therapeutics?
Akari Therapeutics all-time high quarterly working capital is $48.53 M